Statin Therapy Increases Carotid Plaque Echogenicity in Hypercholesterolemic Patients

Ultrasound in Medicine and Biology

Volumn 34, Issue 9, 2008, Pages 1353-1359

  Yamagami, Hiroshi ^a   Sakaguchi, Manabu ^b   Furukado, Shigetaka ^b   Hoshi, Taku ^b   Abe, Yuko ^b   Hougaku, Hidetaka ^b   Hori, Masatsugu ^b   Kitagawa, Kazuo ^b  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; C reactive protein; Carotid intima media thickness; Inflammation; Plaque echogenicity; Statins

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUES; ATORVASTATIN; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CAROTID PLAQUES; ECHOGENICITY; HIGH SENSITIVITIES; INFLAMMATION; INTEGRATED BACKSCATTER; INTERLEUKIN (IL); ISCHEMIC STROKES; PLAQUE ECHOGENICITY; SERUM LEVELS; SIMVASTATIN; STATINS;

BODY FLUIDS; ELECTRIC LOAD MANAGEMENT; SENSITIVITY ANALYSIS; WEIGHT CONTROL;

PHOTOLITHOGRAPHY;

ATORVASTATIN; C REACTIVE PROTEIN; INTERLEUKIN 18; INTERLEUKIN 6; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID STENOSIS; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; PRAVASTATIN; PROBABILITY; PROSPECTIVE STUDIES; PYRROLES; SIMVASTATIN; TRIGLYCERIDES; TUNICA INTIMA;

EID: 49849094291     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2008.01.019     Document Type: Article

References (25)

1. Albert M.A., Danielson E., Ritai N., Ridker P.M., and PRINCE Investigators. Effect of statin therapy on C-reactive protein levels. The pravastatin inflammation/CRP evaluation (PRINCE) A randomised trial and cohort study. JAMA 286 (2001) 64-70
2. Amarenco P., Lavallee P., and Touboul P.J. Stroke prevention, blood cholesterol, and statins. Lancet Neurology 3 (2004) 271-278
3. Blankenberg S., Luc G., Ducimetiere P., Arveiler D., Ferrieres J., Amouyel P., Evans A., Cambien F., and Tiret L. Interleukin-18 and the risk of coronary heart disease in European men: The Protective epidemiological study of myocardial infarction (PRIME). Circulation 108 (2003) 2453-2459
4. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A.W., Livingstone S.J., Thomason M.J., Mackness M., Charlton-Menys V., and Fuller J.H. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative atorvastatin diabetes study (CARDS): Multicentre randomized placebo-controlled trial. Lancet 364 (2004) 685-696
5. Corti R., Fuster V., Fayad Z.A., Worthley S.G., Helft G., Smith D., Weinberger J., Wentzel J., Mizsei G., Mercuri M., and Badimon J.J. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions. Two Year's follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
6. Crisby M., Nordin-Fredriksson G., Shah H., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques. Circulation 103 (2001) 926-933
7. Gronholdt M.L., Nordestgaard B.G., Schroeder T.V., Vorstrup S., and Sillesen H. Ultrasound echolucent carotid plaques predict future strokes. Circulation 104 (2001) 68-73
8. Heart Protection Study Collaboration Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363 (2004) 757-767
9. Jialal I., Stein D., Balis D., Grundy S.M., Adams-Huet B., and Devaraj S. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103 (2001) 1933-1935
10. Kawasaki M., Bouma B.E., Bressner J., Huser S.L., Nadkarni S.K., MacNeill B.D., Jang I.K., Fujiwara H., and Tearney G.J. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol 48 (2006) 81-88
11. Kitagawa K., Hougaku H., Yamagami Y., Hashimoto H., Itoh T., Shimizu Y., Takahashi D., Murata S., Seike Y., Kondo K., Hoshi T., Furukado S., Abe Y., Yagita Y., Sakaguchi M., Tagaya M., Etani H., Fukunaga R., Nagai Y., Matsumoto M., and Hori M. Carotid intima-media thickness and risk of cardiovascular events in high-risk patients-Results of the Osaka Follow-up Study for Carotid Atherosclerosis 2 (OSACA2 Study). Cerebrovasc Dis 24 (2007) 35-42
12. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
13. Mathiesen E.B., Bonaa K.H., and Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis. The Tromso Study. Circulation 103 (2001) 2171-2175
14. Rezaie-Majd A., Maca T., Bucek R.A., Valent P., Muller M.R., Husslein P., Kashanipour A., Minar E., and Baghestanian M. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 22 (2002) 1194-1199
15. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
16. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A., and Braunwald E. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 351 (2005) 20-28
17. Rudd J.H.F., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., Johnstrom P., Davenport A.P., Kirkpatrick J.C., Arch B.N., Pickard J.D., and Weissberg P.L. Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
18. Scartl M., Bocksch W., Koschyk D.H., Voelker W., Karsch K.R., Kreuzer J., Hausmann D., Beckmann S., and Gross M. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 104 (2001) 387-392
19. Smith Jr. S.C., Anderson J.L., Cannon III R.O., Fadl Y.Y., Koenig W., Libby P., Lipshultz S.E., Mensah G.A., Ridker P.M., Rosenson R., and CDC/AHA workshop on markers of inflammation and cardiovascular disease. Application to clinical and public health practice: report from the clinical practice discussion group. Circulation 110 (2004) e550-e553
20. Takemoto M., and Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Arterioscler Thromb Vasc Biol 21 (2001) 1712-1719
21. Takiuchi S., Rakugi H., Honda K., Masuyama T., Hirata N., Ito H., Sugimoto K., Yanagitani Y., Moriguchi K., Okamura A., and Ogihara T. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation 102 (2000) 766-770
22. Watanabe K., Sugiyama S., Kugiyama K., Honda O., Fukushima H., Koga H., Horibata Y., Hirai T., Sakamoto T., Yoshimura M., Yamashita Y., and Ogawa H. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol 46 (2005) 2022-2030
23. Yamagami H., Kitagawa K., Nagai Y., Hougaku H., Sakaguchi M., Kuwabara K., Kondo K., Masuyama T., Matsumoto M., and Hori M. Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke 35 (2004) 677-681
24. Yamagami H., Kitagawa K., Hoshi T., Furukado S., Hougaku H., Nagai Y., and Hori M. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 25 (2005) 1458-1462
25. Yuan C., Mitsumori L.M., Ferguson M.S., Polissar N.L., Echelard D., Ortiz G., Small R., Davies J.W., Kerwin W.S., and Hatsukami T.S. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104 (2001) 2051-2056